Please provide your email address to receive an email when new articles are posted on . demonstrated superiority of thymectomy and prednisone compared to prednisone alone at 3 and 5 years post-surgery ...

Five-year results from the extended randomized MGTX trial demonstrated that the addition of thymectomy to prednisone leads to long-lasting lower quantitative myasthenia gravis (QMG) scores and ...

The researchers note that this finding adds valuable insight for individualized treatment decisions in scenarios where the role of thymectomy is not fully clear. Researchers have identified several ...

BOSTON -- Thymectomy combined with prednisone therapy in patients with nonthymomatous (no thymus tumor) myasthenia gravis (MG) resulted in better three-year patient outcomes than steroid therapy alone ...

Decisions about thymectomy in myasthenia gravis (MG) depend on several variables. Two important categories are whether the patient's thymus gland has thymoma or not and what type of autoantibodies, if ...

Please provide your email address to receive an email when new articles are posted on . Patients with myasthenia gravis — particularly those post-thymectomy — demonstrate an increased odds for having ...

.BUFFALO, N.Y. — The first-ever randomized study of the removal of the thymus gland in treating myasthenia gravis was conducted in 2016. Led by Gil I. Wolfe, MD, SUNY Distinguished Professor and the ...

For several decades, thymectomy has been an option for the treatment of myasthenia gravis, a rare, long-term, autoimmune neuromuscular disease. This randomized clinical trial, carried out in 67 ...

A new study in the New England Journal of Medicine addresses a question doctors have sought to clarify for decades: whether a surgery conducted since the 1940s benefits the patients it targets. The ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Nicholas Silvestri ...